Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Enveric Biosciences Inc (ENVB)

Enveric Biosciences Inc (ENVB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 11,580
  • Shares Outstanding, K 52,685
  • Annual Sales, $ 0 K
  • Annual Income, $ -48,980 K
  • 60-Month Beta 1.77
  • Price/Sales N/A
  • Price/Cash Flow 0.24
  • Price/Book 0.46
Trade ENVB with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.14
  • Most Recent Earnings -0.14 on 03/31/22
  • Next Earnings Date 05/24/22
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 328.45% ( -193.53%)
  • Historical Volatility 113.40%
  • IV Percentile 63%
  • IV Rank 23.17%
  • IV High 1,243.59% on 05/12/22
  • IV Low 52.40% on 01/18/22
  • Put/Call Vol Ratio 0.50
  • Today's Volume 3
  • Volume Avg (30-Day) 8
  • Put/Call OI Ratio 0.01
  • Today's Open Interest 2,557
  • Open Int (30-Day) 3,701

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/22
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.20
  • Growth Rate Est. (year over year) +499,600.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1700 +14.24%
on 05/12/22
0.2900 -33.03%
on 05/02/22
-0.0843 (-30.27%)
since 04/22/22
3-Month
0.1700 +14.24%
on 05/12/22
0.4400 -55.86%
on 03/01/22
-0.0731 (-27.35%)
since 02/24/22
52-Week
0.1700 +14.24%
on 05/12/22
3.7400 -94.81%
on 09/10/21
-2.3058 (-92.23%)
since 05/24/21

Most Recent Stories

More News
American Billionaire Entrepreneurs Bet Millions on Psychedelics

FN Media Group Presents Microsmallcap.com Market Commentary   New York, NY – May 10, 2022 – Billionaire Bob Parsons, the founder of GoDaddy, believes psychedelics can heal trauma. The Marine infantryman...

CYBN.NE : 0.800 (+3.90%)
MYCO.NE : 1.090 (+6.86%)
PYPL : 78.65 (-3.12%)
TSLA : 628.16 (-6.93%)
CYBN : 0.6154 (-9.50%)
MYCOF : 1.0000 (-3.85%)
NUMI.TO : 0.3900 (unch)
NUMIF : 0.2984 (-8.61%)
ATAI : 3.77 (-2.58%)
ENVB : 0.1942 (-11.65%)
Roth Capital Reveals Top Psychedelic Picks in New Industry Report

FN Media Group Presents Microsmallcap.com Market Commentary   New York, NY – April 21, 2022 – Investment banks are continuing to release positive coverage for psychedelic stocks and the latest report...

CYBN.NE : 0.800 (+3.90%)
CYBN : 0.6154 (-9.50%)
ATAI : 3.77 (-2.58%)
EHVVF : 0.0090 (-10.00%)
ENVB : 0.1942 (-11.65%)
NUMI.TO : 0.3900 (unch)
NUMIF : 0.2984 (-8.61%)
New Research Reveals How Psychedelics Are Helping Combat Mental Illness

FN Media Group Presents Microsmallcap.com Market Commentary   New York, NY – March 29, 2022 – Mental health cases are continuing to rise and are taking a serious toll on the healthcare system. Luckily,...

CYBN.NE : 0.800 (+3.90%)
ATAI : 3.77 (-2.58%)
JNJ : 181.40 (+1.09%)
ENVB : 0.1942 (-11.65%)
TNXP : 2.13 (-9.36%)
CYBN : 0.6154 (-9.50%)
Q4 Investor Summit Small Cap & Micro Cap Conference To Offer Opportunity to Meet with C-level Management of 90+ Companies

Small and Micro-cap investors are invited to attend the Q4 Investor Summit being held on November 16-17, 2021. The event is organized by the Investor Summit Group, recognised as a highly reputed brand...

AZ.TO : 6.19 (unch)
AAZZF : 10.8545 (+0.13%)
ACST : 0.9096 (+0.18%)
ATNM : 5.57 (-5.91%)
ADCO.TO : 0.2600 (-5.45%)
ADCOF : 0.2137 (-7.09%)
ALIM : 5.90 (+9.26%)
ACOGF : 0.5131 (-12.74%)
AMST : 0.6164 (+9.56%)
ANVS : 8.61 (-4.12%)
ANPC : 0.3180 (+2.25%)
ARC : 2.92 (+1.04%)
Enveric Biosciences to Participate in Wonderland: Miami Conference

/PRNewswire/ -- Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a patient-centric biotechnology company developing next-generation mental...

ENVB : 0.1942 (-11.65%)
KCSA Psychedelics Virtual Investor Conference Presentations Available for On-Demand Viewing

/PRNewswire/ -- Virtual Investor Conferences in partnership with KCSA Strategic Communications today announced the presentations from the KCSA Psychedelics...

PSIL : 2.74 (-5.52%)
AWKNF : 0.9734 (-7.73%)
ENVB : 0.1942 (-11.65%)
MCURF : 0.0529 (+1.73%)
NVMDF : 0.2107 (-0.14%)
BETRF : 0.0765 (-14.24%)
HUGE : 0.8800 (+0.55%)
MSSTF : 0.3180 (-2.78%)
PSYBF : 0.0467 (-3.71%)
PSYCF : 0.0819 (+9.20%)
BMBIF : 7.9800 (-1.85%)
NMDBF : 0.0669 (+10.76%)
KCSA Psychedelics Virtual Investor Conference Agenda Announced for October 13th & 14th

/PRNewswire/ -- Virtual Investor Conferences in partnership with KCSA Strategic Communications today announced the agenda for the upcoming KCSA Psychedelics...

AWKNF : 0.9734 (-7.73%)
ENVB : 0.1942 (-11.65%)
MCURF : 0.0529 (+1.73%)
NVMDF : 0.2107 (-0.14%)
BETRF : 0.0765 (-14.24%)
MSSTF : 0.3180 (-2.78%)
PSYBF : 0.0467 (-3.71%)
PSYCF : 0.0819 (+9.20%)
BMBIF : 7.9800 (-1.85%)
NMDBF : 0.0669 (+10.76%)
TRYPF : 0.0610 (-3.79%)
WSNAF : 0.1633 (-1.51%)
Enveric Biosciences to Participate in Upcoming Investor Conferences in October 2021

/PRNewswire/ -- Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a patient-centric biotechnology company developing next-generation mental...

ENVB : 0.1942 (-11.65%)
Enveric Biosciences Announces Artificial Intelligence Platform, PsyAI™, Has Identified Viable Drug Candidates from its 'Psybrary' of Psychedelic Molecular Compounds

/PRNewswire/ -- Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a patient-centric biotechnology company developing next-generation mental...

ENVB : 0.1942 (-11.65%)
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Enveric Biosciences, Inc. Merger

WILMINGTON, Del., June 25, 2021 (GLOBE NEWSWIRE) -- Rigrodsky Law, P.A. announces that it is investigating Enveric Biosciences, Inc. (“Enveric”) (NASDAQ CM: ENVB ) regarding possible breaches...

ENVB : 0.1942 (-11.65%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Enveric Biosciences Inc. is a patient-centric biotechnology company endeavoring to enhance the lives of Cancer Treatments with novel cannabinoid medicines. Enveric Biosciences Inc., formerly known as AMERI Holdings Inc., is based in NAPLES, Fla.

See More

Key Turning Points

3rd Resistance Point 0.2651
2nd Resistance Point 0.2421
1st Resistance Point 0.2181
Last Price 0.1942
1st Support Level 0.1711
2nd Support Level 0.1481
3rd Support Level 0.1241

See More

52-Week High 3.7400
Fibonacci 61.8% 2.3763
Fibonacci 50% 1.9550
Fibonacci 38.2% 1.5337
Last Price 0.1942
52-Week Low 0.1700

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar